Found: 2
Select item for more details and to access through your institution.
The phosphatidylserine targeting antibody bavituximab plus pembrolizumab in unresectable hepatocellular carcinoma: a phase 2 trial.
- Published in:
- Nature Communications, 2024, v. 15, n. 1, p. 1, doi. 10.1038/s41467-024-46542-y
- By:
- Publication type:
- Article
Sargramostim (rhu GM-CSF) Improves Survival of Non-Human Primates with Severe Bone Marrow Suppression after Acute, High-Dose, Whole-Body Irradiation.
- Published in:
- Radiation Research, 2021, v. 195, n. 2, p. 191, doi. 10.1667/RADE-20-00131.1
- By:
- Publication type:
- Article